Normal view MARC view ISBD view

Role of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer.

Donahue, James M

Role of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer. [electronic resource] - Journal of surgical oncology Aug 2014 - 97-8 p. digital

Publication Type: Editorial

ISSN: 1096-9098

Standard No.: 10.1002/jso.23648 doi

Subjects--Topical Terms:
Adenocarcinoma--diagnosis
Biomarkers, Tumor--metabolism
Carcinoma, Non-Small-Cell Lung--diagnosis
ErbB Receptors--metabolism
Humans
Lung Neoplasms--diagnosis
Neoplasm Staging
Prognosis
Tumor Suppressor Protein p53--metabolism

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)